Home > Products and Services > Clinical Development

Clinical Development

CNS' focus on strategic expertise, operational integration, and superior partnership provides an important opportunity for all clients, regardless of size to maximize their assets. For smaller, emerging companies, the benefit of scientific, strategic, and execution expertise gathered from across the pharmaceutical and biotechnology industry is therapeutically focused and clear. While CNS’ ability to design and implement development programs from first-in-human through proof of concept studies is key for clients with limited available resources, this offering is also important for large sponsors. Here, ‘shelf’ compounds with financially unfavorable development costs may be re-assessed more efficiently, given CNS’ turn-key clinical development capabilities.

Studies indicate that the areas where our clinical development system can most significantly benefit from improved efficiency lie within early development (Phase 1 and 2 research). Recognizing this, CNS focuses on combining the gains from operational efficiency and scientific/academic relationships to enable more rapid, targeted execution while raising the level of methodological and scientific vigilance. This vigilance is vital in developing central nervous system compounds, given the substantial overlap of therapeutic effects seen with modern psychotropics, as well as the variety and commonality of clinical symptoms across seemingly dissimilar disease states.